$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About Galera Therapeutics, Inc.
Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Sector
Health Technology
CEO
J. Mel Sorensen
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Website
Top Stories
Coming soon.